A top US Food and Drug Administration (FDA) official stated that the midterm congressional election results will not likely ...
BARCELONA – As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' jobs but will instead help them work more efficiently and dedicate ...
As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' ...
Moderator Claire D'Abreu-Hayling (left) and FDA's Sarah Yim participate in fireside chat. (Photo: Joanne S. Eglovitch) BETHESDA, MD – Sarah Yim, director of the US Food and Drug Administration’s (FDA) ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on generative AI (genAI)-enabled medical devices, and stakeholders have offered ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results